Low-power versus high-power laser for holmium laser enucleation of prostate: systematic review and meta-analysis - Scorecard - MDSpire

Low-power versus high-power laser for holmium laser enucleation of prostate: systematic review and meta-analysis

  • By

  • Liping Chen

  • Changqing Chen

  • Congran Li

  • Zhijia Liu

  • Haixia Qiu

  • Hongwei Bai

  • April 17, 2025

  • 0 min

Share

Clinical Scorecard: Comparison of Low-Power and High-Power Lasers in Holmium Laser Enucleation of the Prostate: A Systematic Review and Meta-Analysis

At a Glance

CategoryDetail
ConditionBenign prostatic hyperplasia (BPH) with lower urinary tract symptoms (LUTS)
Key MechanismsHolmium laser enucleation enables precise removal of prostatic tissue with simultaneous coagulation and mechanical morcellation
Target PopulationAdult men undergoing surgical treatment for BPH
Care SettingUrological surgical setting, including minimally invasive procedures

Key Highlights

  • HoLEP is emerging as a new gold standard for surgical treatment of BPH, especially for larger prostates.
  • High-power (80–100 W) lasers offer rapid and precise enucleation but are costly and require specialized equipment.
  • Low-power (20–50 W) lasers are cost-effective, versatile, and potentially comparable in safety and efficacy to high-power lasers.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis of BPH should be based on clinical symptoms including lower urinary tract symptoms and confirmed by appropriate urological evaluation.

Management

  • Consider HoLEP as a minimally invasive surgical option for BPH patients unresponsive to medical therapy.
  • High-power HoLEP is preferred for large prostates due to efficiency but consider low-power HoLEP for cost-effectiveness and versatility.

Monitoring & Follow-up

  • Postoperative assessment should include International Prostate Symptom Score (IPSS), maximum urinary flow rate (Qmax), post-void residual urine volume (PVR), and quality of life (QoL) scores at 3 and 6 months.

Risks

  • Monitor for intraoperative bleeding, hemoglobin decrease, and potential complications associated with TURP syndrome when applicable.
  • Consider the risk-benefit profile of laser power settings in relation to patient comorbidities and prostate size.

Patient & Prescribing Data

Adult men undergoing HoLEP for BPH

Low-power HoLEP demonstrates comparable safety and efficacy to high-power HoLEP with potential benefits in cost and equipment requirements; however, evidence is primarily from prospective comparative studies and RCTs.

Clinical Best Practices

  • Select laser power settings based on prostate size, patient factors, and resource availability.
  • Use HoLEP to achieve precise enucleation with simultaneous coagulation to reduce bleeding.
  • Perform thorough postoperative functional assessments using standardized symptom scores and uroflowmetry.
  • Consider cost and equipment maintenance when choosing between low-power and high-power laser systems.
  • Ensure multidisciplinary review of patient suitability for HoLEP and tailor surgical approach accordingly.

References

Original Source(s)

Related Content